DK0888289T3 - Antikonvulsive, enantiomore aminosyrederivater - Google Patents

Antikonvulsive, enantiomore aminosyrederivater

Info

Publication number
DK0888289T3
DK0888289T3 DK97916897T DK97916897T DK0888289T3 DK 0888289 T3 DK0888289 T3 DK 0888289T3 DK 97916897 T DK97916897 T DK 97916897T DK 97916897 T DK97916897 T DK 97916897T DK 0888289 T3 DK0888289 T3 DK 0888289T3
Authority
DK
Denmark
Prior art keywords
anticonvulsant
enantiomore
amino acid
acid derivatives
animal
Prior art date
Application number
DK97916897T
Other languages
Danish (da)
English (en)
Inventor
Harold Kohn
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21760388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0888289(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Application granted granted Critical
Publication of DK0888289T3 publication Critical patent/DK0888289T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97916897T 1996-03-15 1997-03-17 Antikonvulsive, enantiomore aminosyrederivater DK0888289T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1352296P 1996-03-15 1996-03-15
PCT/US1997/004579 WO1997033861A1 (en) 1996-03-15 1997-03-17 Anticonvulsant enantiomeric amino acid derivatives

Publications (1)

Publication Number Publication Date
DK0888289T3 true DK0888289T3 (da) 2001-09-03

Family

ID=21760388

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97916897T DK0888289T3 (da) 1996-03-15 1997-03-17 Antikonvulsive, enantiomore aminosyrederivater
DK00109377T DK1038522T3 (da) 1996-03-15 1997-03-17 Antikonvulsive enantiomere aminosyrederivater

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK00109377T DK1038522T3 (da) 1996-03-15 1997-03-17 Antikonvulsive enantiomere aminosyrederivater

Country Status (12)

Country Link
EP (2) EP0888289B1 (https=)
JP (1) JP3145414B2 (https=)
AT (2) ATE268169T1 (https=)
AU (1) AU718577B2 (https=)
CA (1) CA2248317C (https=)
DE (3) DE69729392T2 (https=)
DK (2) DK0888289T3 (https=)
ES (2) ES2157567T3 (https=)
FR (1) FR09C0006I2 (https=)
NL (1) NL300376I1 (https=)
PT (2) PT888289E (https=)
WO (1) WO1997033861A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048899A (en) * 1997-03-17 2000-04-11 Research Corporation Tech., Inc. Anticonvulsant enantiomeric amino acid derivatives
EP1642889A1 (en) * 2004-10-02 2006-04-05 Schwarz Pharma Ag Improved synthesis scheme for lacosamide
EP1873527A1 (en) 2006-06-30 2008-01-02 Schwarz Pharma Ag Method for identifying CRMP modulators
US8093426B2 (en) 2007-12-04 2012-01-10 Ranbaxy Laboratories Limited Intermediate compounds and their use in preparation of lacosamide
DE102008059155A1 (de) 2008-11-27 2010-06-02 Ratiopharm Gmbh Trockenverarbeitung und neue Formen von Lacosamid
AR080275A1 (es) 2009-08-06 2012-03-28 Medichem Sa Formas solidas de un derivado de n-( fenilmetil) propanamida y procedimientos de preparacion
JP5564570B2 (ja) * 2009-09-25 2014-07-30 カディラ・ヘルスケア・リミテッド ラコサミドおよびその中間体の調製方法
IT1398044B1 (it) * 2010-01-29 2013-02-07 Archimica Srl Processo per la preparazione della lacosamide
KR20120128667A (ko) 2010-02-08 2012-11-27 낫코 파마 리미티드 라코사미드의 제조방법
WO2011099033A1 (en) * 2010-02-09 2011-08-18 Msn Laboratories Limited Process for preparing (r)-2-acetamido-n-benzyl-3-methoxy-propionamide
EP2399901A1 (en) 2010-06-23 2011-12-28 Archimica GmbH Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide
EP2621893A1 (en) 2010-10-01 2013-08-07 UCB Pharma GmbH Process for the preparation of amino acid derivatives
WO2012051551A1 (en) * 2010-10-15 2012-04-19 Nektar Therapeutics N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
PL2444390T3 (pl) 2010-10-19 2017-06-30 Euticals Gmbh Sposób wytwarzania Lakozamidu
MX2013005974A (es) 2010-12-02 2013-07-29 Ucb Pharma Gmbh Formulacion de lacosamida de administracion una vez al dia.
EP2468261A1 (en) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation of lacosamide
CN104771356A (zh) * 2014-01-09 2015-07-15 山东方明药业集团股份有限公司 一种拉科酰胺注射液及其制备方法
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
EP0194464B1 (en) * 1985-02-15 1991-04-03 Research Corporation Technologies, Inc. (a Delaware corp.) Amino acid derivatives and use thereof for the preparation of an anticonvulsant

Also Published As

Publication number Publication date
FR09C0006I2 (fr) 2009-12-18
PT888289E (pt) 2001-09-28
AU2539497A (en) 1997-10-01
FR09C0006I1 (https=) 2009-04-17
DE69705210T2 (de) 2001-09-20
ATE202079T1 (de) 2001-06-15
JP3145414B2 (ja) 2001-03-12
DE69705210D1 (de) 2001-07-19
DE122009000010I2 (de) 2010-10-21
WO1997033861A1 (en) 1997-09-18
EP1038522B1 (en) 2004-06-02
EP0888289B1 (en) 2001-06-13
EP1038522A2 (en) 2000-09-27
NL300376I1 (nl) 2009-05-06
CA2248317A1 (en) 1997-09-18
DK1038522T3 (da) 2004-10-11
DE69729392T2 (de) 2005-06-02
ATE268169T1 (de) 2004-06-15
JP2000505476A (ja) 2000-05-09
ES2218024T3 (es) 2004-11-16
PT1038522E (pt) 2004-10-29
EP0888289A1 (en) 1999-01-07
DE69729392D1 (de) 2004-07-08
EP1038522A3 (en) 2003-01-15
DE122009000010I1 (de) 2009-05-20
AU718577B2 (en) 2000-04-13
ES2157567T3 (es) 2001-08-16
CA2248317C (en) 2003-12-02

Similar Documents

Publication Publication Date Title
NL300376I1 (nl) Enantiomere anticonvulsieaminozuurderivaten
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
BR9808281A (pt) Compostos, composições farmacêuticas, processo para tratar doenças proliferativas e/ou distúrbios do sistema imune e para preparar um composto, e, uso de um composto
EA199900620A1 (ru) Фталазиноны
BR9912571A (pt) Derivado de diamida de ácido dicarboxìlicoheterocìclico fundido, herbicida, e, processo paraa utilização de um herbicida
PT911331E (pt) Compostos de dibenzoxazepina substituidos composicoes farmaceuticas e metodos de utilizacao
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ES552348A0 (es) Procedimiento de preparar agentes anticonvulsivos derivados de aminoacidos
ES2126075T3 (es) Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa.
ATE399545T1 (de) Mittel zur verringerung der eigeweidefette
EP1034783A4 (en) AMIDE DERIVATIVES
ATE264104T1 (de) Immunmodulierende arzneimittelzusammenstellung
DK526087A (da) Antikonvulsive aminosyrederivater
DK498889D0 (da) Substituerede aromatiske forbindelser med virkning paa centralnervesystemet
EA199900888A1 (ru) Противоревматические средства
FI963568A0 (fi) Peptidijohdannaisia
DE69123757D1 (de) Epoxysuccinamidsäurederivat
ES2171389T3 (es) Derivados anticonvulsivos de aminoacidos.
FI965157A7 (fi) 2-((2,6-dikloorifenyyli)amiini)fenyyliasetoksietikkahapon uudet suolat orgaanisten emäksisten kationien kanssa
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
PT88242A (pt) Processo para a preparacao de eteres e tioeteres tendo actividade terapeutica
BR9506763A (pt) Derivados de carbamoil metil uréia
ATE220544T1 (de) Neue verwendung von pyrazolopyridinverbindungen
ATE48511T1 (de) M-cyanphenethanolamine als tierwachstumsfoerderer und antilipogene mittel.